One-class classification as a novel method of ligand-based virtual screening: the case of glycogen synthase kinase 3β inhibitors.
暂无分享,去创建一个
[1] Francisco Melo,et al. StAR: a simple tool for the statistical comparison of ROC curves , 2008, BMC Bioinformatics.
[2] J. Pin,et al. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. , 2005, Journal of medicinal chemistry.
[3] Egon L. Willighagen,et al. The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..
[4] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[5] P. Greengard,et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. , 2003, Chemistry & biology.
[6] Igor I. Baskin,et al. Virtual screening based on one-class classification , 2011 .
[7] Jane Endicott,et al. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. , 2003, Journal of medicinal chemistry.
[8] J. Gálvez,et al. Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity. , 2003, Bioorganic & medicinal chemistry letters.
[9] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[10] S. Knapp,et al. Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors. , 2003, Journal of molecular biology.
[11] Xiaoling Xie,et al. Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control. , 2009, Journal of medicinal chemistry.
[12] H. Ye,et al. Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3. , 2007, Bioorganic & medicinal chemistry letters.
[13] Vladimir A Palyulin,et al. Structure‐Based Virtual Screening of Glycogen Synthase Kinase 3β Inhibitors: Analysis of Scoring Functions Applied to Large True Actives and Decoy Sets , 2011, Chemical biology & drug design.
[14] J A Swets,et al. Measuring the accuracy of diagnostic systems. , 1988, Science.
[15] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[16] Alexandre Varnek,et al. Chemoinformatics approaches to virtual screening , 2008 .
[17] Igor I Baskin,et al. The One‐Class Classification Approach to Data Description and to Models Applicability Domain , 2010, Molecular informatics.
[18] J. Kunitomo,et al. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta. , 2009, Bioorganic & medicinal chemistry.
[19] I. Tikhonova,et al. Virtual screening of organic molecule databases. Design of focused libraries of potential ligands of NMDA and AMPA receptors , 2004 .
[20] R. Hariharan,et al. GSK3β: role in therapeutic landscape and development of modulators , 2010, British journal of pharmacology.